ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000230565.1	Axitinib	Chronic Lymphocytic Leukemia	0.047443861	Resistant
ENSG00000230565.1	Axitinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.03052609	Sensitive